Extensive rhabdomyolysis after streptokinase therapy for acute myocardial infarction demonstrated by Tc-99m PYP scintigraphy.
Emmett
L M
LM
Department of Nuclear Medicine, Concord Hospital, Australia.
Patel
N C
NC
Thanakrishnan
K
K
Van der Wall
H
H
Magee
M
M
Allman
K C
KC
D000368:Aged; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000139:chemically induced / Q000628:therapy; D012206:Rhabdomyolysis / Q000139:chemically induced / Q000000981:diagnostic imaging*; D013300:Streptokinase / Q000009:adverse effects*; D016698:Technetium Tc 99m Pyrophosphate; D015912:Thrombolytic Therapy / Q000009:adverse effects; D014915:Whole-Body Counting
D005343:Fibrinolytic Agents; D019275:Radiopharmaceuticals; D016698:Technetium Tc 99m Pyrophosphate; D013300:Streptokinase